Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies

NAActive, not recruitingINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

November 21, 2017

Primary Completion Date

September 27, 2023

Study Completion Date

September 27, 2025

Conditions
Myelodysplastic SyndromesChronic Myelomonocytic Leukemia-1Cytopenia
Interventions
DIETARY_SUPPLEMENT

Vitamin C (ascorbic acid)

Monotherapy with oral vitamin C supplementation to elevate plasma vitamin C level to the upper end of the physiological range.

OTHER

Placebo

Placebo

Trial Locations (5)

2100

Rigshospitalet, Copenhagen

2730

Herlev University Hospital, Copenhagen

90033

Keck Hospital of University of Southern California, Los Angeles

Unknown

Aalborg University Hospital, Aalborg

Odense University Hospital, Odense

All Listed Sponsors
collaborator

Van Andel Institute - Stand Up To Cancer Epigenetics Dream Team

UNKNOWN

collaborator

University of Southern California

OTHER

collaborator

Imperial College London

OTHER

collaborator

University of Copenhagen

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Technical University of Denmark

OTHER

collaborator

Aalborg University Hospital

OTHER

lead

Rigshospitalet, Denmark

OTHER